Student Research Symposium Program Portal: Submission #58
Submission information
Submission Number: 58
Submission ID: 7821
Submission UUID: 73ce831f-6177-4d54-9ac2-35897a059ba4
Submission URI: /student-research/symposium/research-symposium-program-portal
Submission Update: /student-research/symposium/research-symposium-program-portal?token=cNNwtN9MQPBijnLDxmJEPojdtQqGPmh1arTgdDquD80
Created: Wed, 02/05/2025 - 05:19 PM
Completed: Wed, 02/05/2025 - 05:29 PM
Changed: Tue, 04/01/2025 - 08:31 AM
Remote IP address: 67.146.133.52
Submitted by: Anonymous
Language: English
Is draft: No
Webform: Research Symposium Program Portal WF
Submitted to: Student Research Symposium Program Portal
First Name: Cheyenne Last Name: Sapp Pronouns: {Empty} FSU Student Email: ccs22c@fsu.edu Student Photo: https://pc.fsu.edu/system/files/webform/research_portal/7821/IMG_4367.jpg Major(s): Doctorate of Nurse Anesthesia Practice Student Bio: I am a student in the Class of 2025- Doctor of Nurse Anesthesia Practice at Florida State University. I am passionate about the practice of anesthesia and furthering evidence based practice through research. I plan to practice in my hometown of Dothan, Alabama upon graduation. Poster Title: Post-Anesthesia Care Unit Times in Patients Reversed from Aminosteroid Paralytics with Sugammadex versus Neostigmine and Glycopyrrolate Combination Abstract: Neuromuscular blockade (NMB) reversal is vital for anesthesia care to prevent residual blockade, which can lead to respiratory complications and delayed recovery. This quality improvement project evaluated sugammadex, a selective NMB reversal agent, compared to the traditional neostigmine-glycopyrrolate, focusing on postoperative care unit (PACU) times in adult patients undergoing general anesthesia with rocuronium or vecuronium. Evidence from clinical guidelines and studies supported sugammadex's advantages in efficiency, safety, and cost-effectiveness. Implemented at a facility in Dothan, Alabama, the project addressed financial concerns through education, aiming to increase sugammadex utilization. Usage increased modestly by 1.38% (from 434 to 440 cases), reflecting improved provider confidence and highlighting the value of overcoming barriers to enhance patient safety and operating room efficiency. Research Mentor Name: Dr. Jason Smith, DNAP, APRN, CRNA Research Mentor's College (or High School): Florida State University Research Mentor's Department (or Subject): Nurse Anesthesia Research Mentor's Email: jcsmith3@fsu.edu Additional Research Mentor(s): {Empty} Co-presenter(s): Shelby Ragan, SRNA Keywords: Reversal, Neostigmine, Glycopyrrolate, Sugammadex Poster Session/Number: https://pc.fsu.edu/student-research/symposium/symposium-program-2025/dnap Work: Complete Presentation Modality: Synchronous Online Presentation Poster PDF: https://pc.fsu.edu/system/files/webform/research_portal/7821/DNAP%20Poster%20.pdf Poster Thumbnail: https://pc.fsu.edu/system/files/webform/research_portal/7821/Screen%20Shot%202025-02-05%20at%204.28.38%20PM.png I will be printing my poster: No Year: 2025 Annual description: 5th annual Undergraduate Research Symposium, April 17, 2025 Update URL: https://pc.fsu.edu/student-research/symposium/research-symposium-program-portal?element_parents=elements/student_photo&ajax_form=1&_wrapper_format=drupal_ajax&token=cNNwtN9MQPBijnLDxmJEPojdtQqGPmh1arTgdDquD80 {Empty}